You are required to be logged in to access the full website
Click here if you have forgotten your username or password
29 May 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd announced on Friday the launch of OPUVIZ (aflibercept) 40 mg/mL solution for injection in a vial across Europe.OPUVIZ, an aflibercept biosimilar referencing Regeneron Pharmac...
29 May 2026 - Clinical-stage oncology therapeutics company Whitehawk Therapeutics Inc (Nasdaq:WHWK) announced on Thursday that its president and CEO, Dave Lennon, PhD, will present at the Jefferies 2026 Global Healthcare Conference in New York City, ...
29 May 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HK:01801) and US-based pharmaceutical company Pfizer Inc (NYSE:PFE), have announced on Thursday that they have entered into a strategic global licensing and collaboration agreeme...
29 May 2026 - Pharmaceutical company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that the US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to include evidence in the TREMFYA (...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe